COVID-19 trial now recruiting participants

Adults aged 18 – 49 years with one or more chronic condition(s) or adults aged 50+ years who tested positive for COVID with symptoms starting within the last five days can participate.

St. Michael’s researcher secures $10 million in funding to study COVID-19 treatments

CanTreatCOVID study investigates the effectiveness of COVID treatments

CTV News Toronto – July 28, 2022

Newly announced CIHR-funded COVID-19 research includes Memorial researchers

Memorial University – July 7, 2022

NOSM University researchers involved in COVID-19 medication study

Antioxidant therapy: novel and affordable addition to CanTreatCOVID trial

Infectious Disease Physician Seeks COVID Patients for New CanTreatCOVID Trial

Subscribe to our newsletter

Sign up for our newsletter to keep on top of the latest CanTreatCOVID study updates and become part of our community.